Related Experiment Video
Updated: Feb 4, 2026

Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
Applications of micro/nano drug delivery systems in cancer pain management
Shizhen Geng1, Yurou Zhang2, Zhehao Zhang3
1Department of Anesthesiology, Pain and Perioperative Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Abstract:
Cancer pain, a critical complication associated with advanced malignant tumors, significantly diminishes patients' quality of life and complicates therapeutic management due to its multifactorial pathophysiology. Current clinical analgesics often face limitations such as tolerance, addiction, and dose-dependent systemic toxicity. In contrast, micro/nano drug delivery systems (MNDDs) have emerged as promising strategies for managing cancer pain, owing to their unique advantages in precise targeting, including tumor-selective and neuropathic pain pathway targeting, controlled release, and multi-modal synergistic therapeutic effects. This review comprehensively examines the pathophysiological mechanisms underlying cancer pain, critically analyzes the pharmacological constraints and clinical limitations of existing analgesic regimens, and summarizes recent advances in engineered MNDDs. Additionally, we discuss the translational potential of multifunctional MNDDs, offering a multidisciplinary perspective to advance the development of precision-engineered, toxicity-minimized analgesic interventions.
Insights
Micro/nano drug delivery systems (MNDDs) offer advanced solutions for cancer pain management, overcoming limitations of traditional analgesics. These systems provide targeted delivery and controlled release for improved therapeutic effects and reduced toxicity.
Area of Science:
- Oncology
- Pharmacology
- Biomedical Engineering
Background:
- Cancer pain significantly impacts patient quality of life and treatment efficacy.
- Existing analgesics have limitations including tolerance, addiction, and systemic toxicity.
- Multifactorial pathophysiology of cancer pain necessitates novel therapeutic strategies.
Purpose of the Study:
- To review the pathophysiology of cancer pain.
- To analyze limitations of current analgesic treatments.
- To summarize advances in micro/nano drug delivery systems (MNDDs) for cancer pain.
Main Methods:
- Comprehensive literature review of cancer pain mechanisms.
- Critical analysis of pharmacological constraints of conventional analgesics.
- Summary of recent developments in engineered MNDDs.
Main Results:
- MNDDs show promise for precise targeting (tumor and neuropathic pathways).
- MNDDs enable controlled drug release and multi-modal synergistic effects.
- Engineered MNDDs offer potential for toxicity-minimized analgesic interventions.
Conclusions:
- MNDDs represent a promising strategy for effective cancer pain management.
- Further development of multifunctional MNDDs is crucial for precision analgesia.
- A multidisciplinary approach is needed to advance MNDD-based cancer pain therapies.
Related Concept Videos
Analgesia and Pain Management
Control Systems: Applications
In modern vehicles, control systems manage various functions to enhance performance and safety. The steering wheel and accelerator are primary inputs in a car's control system. The...
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Enteral Route
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...

